Michael Martin

3.9k total citations · 2 hit papers
46 papers, 2.6k citations indexed

About

Michael Martin is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Michael Martin has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 28 papers in Epidemiology and 23 papers in Virology. Recurrent topics in Michael Martin's work include HIV/AIDS Research and Interventions (31 papers), HIV Research and Treatment (23 papers) and HIV, Drug Use, Sexual Risk (21 papers). Michael Martin is often cited by papers focused on HIV/AIDS Research and Interventions (31 papers), HIV Research and Treatment (23 papers) and HIV, Drug Use, Sexual Risk (21 papers). Michael Martin collaborates with scholars based in Thailand, United States and Uganda. Michael Martin's co-authors include Kachit Choopanya, Suphak Vanichseni, Philip A. Mock, Udomsak Sangkum, Pravan Suntharasamai, Janet M. McNicholl, Sithisat Chiamwongpaet, Somyot Kittimunkong, Lynn Paxton and Manoj Leethochawalit and has published in prestigious journals such as The Lancet, PLoS ONE and Cancer Research.

In The Last Decade

Michael Martin

45 papers receiving 2.6k citations

Hit Papers

Antiretroviral prophylaxis for HIV infection in injectin... 2006 2026 2012 2019 2013 2006 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
    2013 1.1k citations Kachit Choopanya, Michael Martin et al. profile →
  2. Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand
    2006 569 citations Punnee Pitisuttithum, Peter B. Gilbert et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Martin Thailand 20 1.8k 1.6k 939 592 331 46 2.6k
Marcel E. Curlin United States 20 2.0k 1.1× 1.2k 0.8× 667 0.7× 542 0.9× 257 0.8× 52 2.3k
Colleen F. Kelley United States 28 2.0k 1.1× 1.5k 0.9× 667 0.7× 585 1.0× 545 1.6× 90 2.8k
Sodsai Tovanabutra United States 28 1.5k 0.8× 765 0.5× 1.4k 1.5× 282 0.5× 276 0.8× 102 2.4k
Kachit Choopanya Thailand 29 3.4k 1.9× 2.7k 1.7× 2.1k 2.3× 912 1.5× 578 1.7× 67 4.4k
Frances Priddy United States 19 1.1k 0.6× 672 0.4× 607 0.6× 291 0.5× 323 1.0× 45 1.6k
Pravan Suntharasamai Thailand 27 1.6k 0.9× 1.5k 0.9× 780 0.8× 486 0.8× 254 0.8× 64 2.8k
Hui Xing China 31 2.8k 1.5× 1.4k 0.8× 2.4k 2.6× 297 0.5× 183 0.6× 192 3.4k
Suphak Vanichseni Thailand 31 3.5k 1.9× 2.6k 1.6× 2.0k 2.1× 916 1.5× 586 1.8× 69 4.2k
Yuhua Ruan China 37 3.7k 2.0× 2.8k 1.7× 1.9k 2.1× 960 1.6× 657 2.0× 245 4.7k
David van de Vijver Netherlands 29 2.8k 1.5× 1.6k 1.0× 1.8k 1.9× 154 0.3× 136 0.4× 122 4.2k

Countries citing papers authored by Michael Martin

Since Specialization
Citations

This map shows the geographic impact of Michael Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Martin more than expected).

Fields of papers citing papers by Michael Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Martin. The network helps show where Michael Martin may publish in the future.

Co-authorship network of co-authors of Michael Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Martin. A scholar is included among the top collaborators of Michael Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Martin. Michael Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srithanaviboonchai, Kriengkrai, Theerawit Tasaneeyapan, Thananda Naiwatanakul, et al.. (2024). Establishment, Implementation, Initial Outcomes, and Lessons Learned from Recent HIV Infection Surveillance Using a Rapid Test for Recent Infection Among Persons Newly Diagnosed With HIV in Thailand: Implementation Study. JMIR Public Health and Surveillance. 10. e65124–e65124. 1 indexed citations
2.
Khalil, George, Amy Martin, Michael Martin, et al.. (2020). Altered Antibody Responses in Persons Infected with HIV-1 While Using Preexposure Prophylaxis. AIDS Research and Human Retroviruses. 37(3). 189–195. 5 indexed citations
3.
Martin, Michael, Suphak Vanichseni, Udomsak Sangkum, et al.. (2019). HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995–2012. EClinicalMedicine. 9. 44–51. 11 indexed citations
4.
Ruone, Susan, Philip A. Mock, George Khalil, et al.. (2019). HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis. AIDS. 33(15). 2299–2307. 2 indexed citations
5.
Reginster, Jean‐Yves, F. Bianic, Ross T. Campbell, et al.. (2017). Abaloparatide For Risk Reduction of Nonvertebral And Vertebral Fractures In Postmenopausal Women With Osteoporosis: A Network Meta-Analysis. Value in Health. 20(9). A527–A527. 4 indexed citations
6.
Kittimunkong, Somyot, Sriprapa Nateniyom, Virat Klinbuayaem, et al.. (2017). Implementing an isoniazid preventive therapy program for people living with HIV in Thailand. PLoS ONE. 12(9). e0184986–e0184986. 9 indexed citations
7.
Page, Kimberly, Judith I. Tsui, Lisa Maher, et al.. (2015). Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(Supplement 2). S169–S175. 30 indexed citations
8.
Suntharasamai, Pravan, Michael Martin, Kachit Choopanya, et al.. (2015). Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, Thailand. PLoS ONE. 10(12). e0145859–e0145859. 16 indexed citations
9.
Munsakul, Warangkana, et al.. (2015). Dual contraceptive method use and pregnancy intention among people living with HIV receiving HIV care at six hospitals in Thailand. Reproductive Health. 13(1). 8–8. 15 indexed citations
10.
Colby, Donn, Kriengkrai Srithanaviboonchai, Suphak Vanichseni, et al.. (2015). HIV pre‐exposure prophylaxis and health and community systems in the Global South: Thailand case study. Journal of the International AIDS Society. 18(4S3). 19953–19953. 25 indexed citations
11.
Martin, Michael, Suphak Vanichseni, Pravan Suntharasamai, et al.. (2015). The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs. AIDS. 29(7). 819–824. 79 indexed citations
12.
Smith, Dawn K., Michael Martin, Amy Lansky, Jonathan Mermin, & Kachit Choopanya. (2013). Update to Interim guidance for preexposure prophylaxis (PrEP) for the prevention of HIV infection : PrEP for injecting drug users. MMWR Morbidity and Mortality Weekly Report. 62(23). 463. 76 indexed citations
13.
McNicholl, Janet M., J. Steven McDougal, Punneeporn Wasinrapee, et al.. (2011). Assessment of BED HIV-1 Incidence Assay in Seroconverter Cohorts: Effect of Individuals with Long-Term Infection and Importance of Stable Incidence. PLoS ONE. 6(3). e14748–e14748. 9 indexed citations
14.
Martin, Michael, Suphak Vanichseni, Pravan Suntharasamai, et al.. (2010). Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999–2003. International Journal of Drug Policy. 21(4). 296–301. 30 indexed citations
15.
16.
Park, Sarah Y., Chris Van Beneden, Tamara Pilishvili, et al.. (2009). Invasive Pneumococcal Infections among Vaccinated Children in the United States. The Journal of Pediatrics. 156(3). 478–483.e2. 50 indexed citations
17.
Kittikraisak, Wanitchaya, Frits van Griensven, Michael Martin, et al.. (2009). Blood and Seminal Plasma HIV-1 RNA Levels Among HIV-1-Infected Injecting Drug Users Participating in the AIDSVAX B/E Efficacy Trial in Bangkok, Thailand. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(5). 601–608. 5 indexed citations
18.
Pitisuttithum, Punnee, Peter B. Gilbert, Marc Gurwith, et al.. (2006). Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand. The Journal of Infectious Diseases. 194(12). 1661–1671. 569 indexed citations breakdown →
19.
Nguyen, Lily H. P., Ming Li, Thanyanan Chaowanachan, et al.. (2004). CCR5 promoter human haplogroups associated with HIV-1 disease progression in Thai injection drug users. AIDS. 18(9). 1327–1333. 22 indexed citations
20.
Torres, Ramón A., et al.. (1993). Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. The American Journal of Medicine. 95(6). 573–583. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcel E. Curlin Breakdown of academic impact, for papers by Colleen F. Kelley Breakdown of academic impact, for papers by Sodsai Tovanabutra Breakdown of academic impact, for papers by Kachit Choopanya Breakdown of academic impact, for papers by Frances Priddy Breakdown of academic impact, for papers by Pravan Suntharasamai Breakdown of academic impact, for papers by Hui Xing Breakdown of academic impact, for papers by Suphak Vanichseni Breakdown of academic impact, for papers by Yuhua Ruan Breakdown of academic impact, for papers by David van de Vijver
Rankless by CCL
2026